Nahdi Medical Company (TADAWUL:4164)
Saudi Arabia · Delayed Price · Currency is SAR 95.50
-0.75 (-0.78%)
Aug 13, 2026, 3:19 PM AST
Nahdi Medical Company Cash Flow Statement
Financials in millions SAR. Fiscal year is January - December.
Millions SAR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 788.08 | 830.74 | 820.72 | 892.62 | 887.81 | 812.53 |
Depreciation & Amortization | 781.48 | 763.17 | 675.92 | 594.95 | 575.75 | 550.48 |
Other Amortization | 32.01 | 31.53 | 27.52 | 23.13 | 20.89 | 21.02 |
Loss (Gain) From Sale of Assets | -0.7 | -0.49 | -1.54 | -0.22 | 17.42 | -0.03 |
Asset Writedown & Restructuring Costs | - | - | -1.6 | -0.5 | -10.11 | -19.49 |
Provision & Write-off of Bad Debts | 3.25 | 2.69 | -0.19 | -4.49 | 3.19 | 5.87 |
Other Operating Activities | 60.55 | 31.04 | -18.16 | -46.46 | 120.43 | -23.01 |
Change in Accounts Receivable | -36.52 | -128.62 | 37.54 | -38.16 | 6.89 | -47.65 |
Change in Inventory | -373.17 | -628.34 | -333.74 | -214.62 | -127.01 | 85.85 |
Change in Accounts Payable | 111.13 | 170.05 | 338.32 | 257.14 | 153.17 | 43.74 |
Change in Other Net Operating Assets | 173.28 | 61.95 | -53.44 | -147.37 | 19.44 | -95.34 |
Operating Cash Flow | 1,534 | 1,134 | 1,491 | 1,316 | 1,668 | 1,334 |
Operating Cash Flow Growth | 4.89% | -23.98% | 13.32% | -21.09% | 25.03% | -15.88% |
Capital Expenditures | -358.87 | -387.09 | -339.53 | -353.86 | -250.27 | -282.57 |
Sale of Property, Plant & Equipment | 0.7 | 0.49 | 1.57 | 0.25 | 0.1 | 7.1 |
Sale (Purchase) of Intangibles | -29.22 | -30.53 | -44.97 | -30.65 | -24.97 | -23.89 |
Investment in Securities | -276.84 | - | - | - | - | - |
Other Investing Activities | 63.29 | 62.8 | 54.92 | 52.7 | - | - |
Investing Cash Flow | -600.94 | -354.33 | -328.01 | -331.56 | -275.13 | -299.36 |
Long-Term Debt Repaid | - | -453.96 | -401.96 | -435.67 | -416.96 | -382.07 |
Total Debt Repaid | -468.47 | -453.96 | -401.96 | -435.67 | -416.96 | -382.07 |
Net Debt Issued (Repaid) | -468.47 | -453.96 | -401.96 | -435.67 | -416.96 | -382.07 |
Common Dividends Paid | -728 | -728 | -715 | -715 | -300.3 | -1,260 |
Financing Cash Flow | -1,196 | -1,182 | -1,117 | -1,151 | -717.26 | -1,642 |
Foreign Exchange Rate Adjustments | -0.03 | 0.19 | 0.77 | -0.45 | -0.21 | -0.02 |
Net Cash Flow | -263.19 | -402.37 | 47.15 | -166.65 | 675.27 | -607.49 |
Free Cash Flow | 1,175 | 746.64 | 1,152 | 962.17 | 1,418 | 1,051 |
Free Cash Flow Growth | 5.49% | -35.18% | 19.71% | -32.13% | 34.83% | -18.50% |
Free Cash Flow Margin | 11.17% | 7.31% | 12.19% | 11.04% | 16.45% | 13.04% |
Free Cash Flow Per Share | 9.04 | 5.74 | 8.86 | 7.40 | 10.90 | 8.09 |
Levered Free Cash Flow | 1,214 | 397.98 | 814.89 | 645.7 | 1,040 | 712.08 |
Unlevered Free Cash Flow | 1,269 | 452.98 | 860.96 | 677.23 | 1,071 | 761.38 |
Cash Interest Paid | 140.39 | 141.86 | 115.87 | 50.46 | 79.38 | 78.88 |
Change in Working Capital | -125.29 | -524.96 | -11.32 | -143 | 52.49 | -13.4 |